Lidia Wrobel

Has grant

Group Leader

International Institute of Molecular and Cell Biology
Country flagPoland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Spatial organisation of protein quality control in neurodegenerative diseases

Open Date: 2025-01-01

Close Date: 2029-12-01

Grant: Open

Nuclear protein quality control in neurodegeneration

Open Date: 2024-10-01

Close Date: 2027-09-01

Grant: Close

Autophagy regulators acting via Annexin A2

Open Date: 2016-11-01

Close Date: 2018-10-01

Grant: Close

Rola procesów redoks w biogenezie mitochondrialnych białek błonowych (ang. Redox processes in the biogenesis of mitochondrial inner membrane proteins)

Open Date: 2013-10-01

Close Date: 2014-09-30

Articles (4)

Year:

2025

Year:

2025

Autophagy is a conserved pathway where cytoplasmic contents are engulfed by autophagosomes, which then fuse with lysosomes enabling their degradation. Mutations in core autophagy genes cause neurological conditions, and autophagy defects are seen in neurodegenerative diseases such as Parkinson’s disease and Huntington’s disease. Thus, we have sought to understand the cellular pathway perturbations that autophagy-perturbed cells are vulnerable to by seeking negative genetic interactions such as synthetic lethality in autophagy-null human cells using available data from yeast screens. These revealed that loss of proteasome and nuclear pore complex components cause synergistic viability changes akin to synthetic fitness loss in autophagy-null cells. This can be attributed to the cytoplasm-to-nuclear transport of proteins during autophagy deficiency and subsequent degradation of these erstwhile cytoplasmic proteins by nuclear proteasomes. As both autophagy and cytoplasm-to-nuclear transport are defective in Huntington’s disease, such cells are more vulnerable to perturbations of proteostasis due to these synthetic interactions.

Year:

2024

The AAA + -ATPase valosin-containing protein (VCP; also called p97 or Cdc48), a major protein unfolding machinery with a variety of essential functions, localizes to different subcellular compartments where it has different functions. However, the processes regulating the distribution of VCP between the cytosol and nucleus are not understood. Here, we identified p37 (also called UBXN2B) as a major factor regulating VCP nucleocytoplasmic shuttling. p37-dependent VCP localization was crucial for local cytosolic VCP functions, such as autophagy, and nuclear functions in DNA damage repair. Mutations in VCP causing multisystem proteinopathy enhanced its association with p37, leading to decreased nuclear localization of VCP, which enhanced susceptibility to DNA damage accumulation. Both VCP localization and DNA damage susceptibility in cells with such mutations were normalized by lowering p37 levels. Thus, we uncovered a mechanism by which VCP nucleocytoplasmic distribution is fine-tuned, providing a means for VCP to respond appropriately to local needs.

Year:

2024

Collaborators (2)

Gabriel Balmus

Principal Investigator

University of Cambridge

UNITED KINGDOM
View details

David C. Rubinsztein

University of Cambridge

UNITED KINGDOM
View details